Form4insider filings, from the source

SEC Form 4 · accession 0001093557-16-000702

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Barbara Kahn
Director
Period of report
May 8, 2014
Accepted (ET)
Sep 14, 2016 · 8:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 8, 2014S7,500$30.1139D4,791D
Common StockF3,F4Sep 12, 2016S5,000$92.9023D24,304Iby Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

CONFIRMING STATEMENT: This Statement confirms that the undersigned Barbara Kahn, has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: September 9, 2016 /s/ BARBARA KAHN Barbara Kahn